Medicare: Eli Lilly spurns CMS refusal to cover PET scans with beta-amyloid agents

September 30, 2013 by Arezu Sarvestani

Medicare regulators reject reimbursement coverage for positron emission tomography beta-amyloid imaging, with exceptions for use in excluding Alzheimer's disease and in "clinically difficult differential diagnoses."

Medicare denies coverage for new PET agents

The Centers for Medicare & Medicaid Services ruled against new reimbursement coverage for beta-amyloid imaging agents in use with positron emission tomography scans with exceptions for certain indications.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp